On March 11, 2023, the ranking list of Drug Clinical Trial Quantity in National GCP Institutions was grandly released. The First Affiliated Hospital (FAH) of Xi’an Jiaotong University (XJTU) ranked 24^th nationwide, still ranking 1^st in the northwest region.

"CCHRPP Drug Clinical Trial Quantity in National GCP Institutions" (abbreviated as trial quantity) is formulated by statistical data analysis by the expert working group organized by CCHRPP under the guidance of the expert working group of the ranking list of Drug Clinical Trial Quantity in National GCP Institutions. All data are obtained from "Drug Clinical Trial Registration and Information Publicity Platform" of CDE, which reflects drug clinical trial institutions’ support and promotion for biomedical research and development to certain extent. The implementation volumes of drug clinical trials from 2021 to 2023 are collected, and the value indexes and weights of research and development are also considered, forming the new ranking list. The quantity and quality of drug clinical trials in recent 3 years are assessed and adopted to reflect the contribution, the scale of operation and maintenance and the degree of efforts of GCP institutions for new drug research and development.